Funding for this research was provided by:
National Health and Medical Research Council (1137587, 1084706, 1150078, 1173666)
University of New South Wales (2018-ECR-001)
Received: 23 March 2020
Accepted: 19 February 2021
First Online: 2 March 2021
: The use of clinical samples described in this study are covered by following institutional ethics approvals: Human Research Ethics Committee of University of New South Wales (reference numbers HC190074 and HC14201) and Human Research Ethics Committees of Justice Health (reference number GEN 31/05), New South Wales Department of Corrective Services (05/0884), all located in Sydney, Australia. Written informed consent was obtained from subjects before blood samples were taken. Minors were not recruited.
: Not applicable as the manuscript does not have any individual identifiable patient data.
: CR, NR, PL, RB, KB, SC and ARL have no competing interests. MS have received travel support from Oxford Nanopore Technologies.